Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
by seasky on Fri Aug 15, 2008 12:00 AM
A promising new liver cancer treatment called "Thermodox" is now in Phase 3 clinical trial and recruiting. The following link is a recent news about Thermodox for liver cancer:
http://www.celsion.com/ releasedetail.cfm?ReleaseID=318808" target="_blank" rel="nofollow">http://www.celsion.com/ releasedetail.cfm?ReleaseID=318808
Here is the FDA's Thermodox Phase 3 clinical trial website:
Here is North Shore University Hospital's newsletter, info about Thermodox is on page 22.
Here is some history of Thermodox:
More info can be found from the company (Celsion) that developed Thermodox treatment:
The recent news about Thermodox link:
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.